Greater awareness of biosimilars and shared decision-making among patients attending rheumatology practices in Colorado, United States: Real-world data

Figure 1 True/false questions regarding various aspects of biosimilars.

Figure 2 The percentage of survey respondents who provided the correct answer regarding various aspects of shared decision-making.

Figure 3 Motivation to learn more about biosimilars and shared decision-making as well as interest in discussing each subject with others (e. g., medical professionals, family members, friends).

Figure 4 The responses to the question “What would be your preferred style to learn more about biosimilar agents and shared decision-making?”.